The Blood Glucose Monitoring Devices Market is entering a period of sustained expansion as diabetes prevalence rises worldwide, populations age, and patients increasingly seek convenient ways to monitor glucose levels. The global Blood Glucose Monitoring Devices Market was valued at USD 15.5 billion in 2025 and is projected to grow from USD 16.8 billion in 2026 to USD 30.1 billion by 2033, registering a CAGR of 8.8% from 2026 to 2033. North America led the global market with a 38.0% revenue share in 2025, while Asia Pacific is expected to record the fastest growth during the forecast period.
At the center of this expansion is the growing need for timely glucose measurement, better diabetes self-management, and technologies that can connect patients, healthcare professionals, and digital health platforms.
Why Is the Blood Glucose Monitoring Devices Market Growing?
The first answer is the expanding diabetes population.
More than 500 million people worldwide were estimated to be living with diabetes, with a global prevalence of 6.1% according to the June 2023 IHME data cited in the source. The IDF estimated approximately 537 million people with diabetes in 2021, with projections of 643 million by 2030 and 783 million by 2045.
The burden is particularly significant in regions where prevalence is already high:
North Africa and the Middle East: 9.3% prevalence, projected to reach 16.8% by 2050
Latin America and the Caribbean: projected prevalence of 11.3%
Diabetes remains among the world's top 10 causes of death and disability
Growing awareness of prevention and diabetes management, along with new product introductions, is therefore creating a larger addressable market.
Why Does the Aging Population Matter?
Diabetes becomes more prevalent with age, making demographic aging another important market driver.
The U.S. National Diabetes Statistics Report cited 27.2 million adults aged 65 years or older with prediabetes in 2021. Research also indicates that real-time CGM can be effective and safe for adults aged 65 years and above with type 2 diabetes, with improvements in HbA1c compared with BGM.
Download a free sample report or claim your copy of this full market intelligence report
This means the market opportunity is not only about the number of diabetes patients. It also involves the growing number of older adults who need convenient and reliable monitoring.
Which Product Currently Leads?
Self-monitoring blood glucose devices held 66.0% of market revenue in 2025.
The segment remains important because SMBG provides an affordable and user-friendly method for daily glucose management.
Its product ecosystem includes:
Blood glucose meters
Traditional BGMs
Smart BGMs
Testing strips
Lancets
Portable meters have become increasingly discreet and convenient. Products referenced in the source include FreeStyle Lite, CONTOUR NEXT USB, OneTouch UltraEasy, Accu-Chek Aviva Nano, Accu-Chek Mobile, and TRUEone.
But the market is simultaneously moving toward continuous monitoring.
Where Does CGM Fit?
Continuous blood glucose monitoring is expected to show lucrative growth during the forecast period.
Unlike conventional testing, CGM systems continuously measure glucose in interstitial fluid using a sensor positioned under the skin. Transmitters and receivers then communicate the readings to a monitor or connected device. These systems can provide readings every five minutes and are particularly valuable for type 1 diabetes and hypoglycemia prevention.
The wider CGM ecosystem includes:
Sensors + Transmitters/Receivers + Insulin Pumps
The growing adoption of CGM demonstrates the market's movement toward continuous, real-time information rather than isolated readings.
Why Is Bluetooth So Important?
Bluetooth-enabled devices captured 50.2% of the connectivity segment in 2025.
The reason is straightforward: connectivity turns a glucose meter into part of a larger digital health workflow.
Bluetooth-enabled devices can:
Send glucose information to smartphones, tablets, and computers
Reduce manual data-entry errors
Improve glucose tracking
Support alerts when levels move outside target ranges
Enable information sharing with healthcare professionals
Improve patient engagement and treatment adherence
Other connectivity technologies include Wi-Fi, NFC, and USB.
Why Do Hospitals Lead the End-Use Segment?
Hospitals accounted for 41.1% of global revenue in 2025.
The increase in diabetic hospitalizations and healthcare spending has encouraged hospitals to adopt monitoring devices that provide rapid and reliable glucose information. These technologies support both inpatient and outpatient care while also enabling patient information to be stored and transferred.
The COVID-19 pandemic highlighted this value further. Regulatory changes allowed broader CGM access, while real-time CGM was used during lockdowns to support glycemic control, reduce time out of range, and manage glucose variability.
At the same time, home care is expected to experience lucrative growth from 2026 to 2033 as patients increasingly monitor glucose outside traditional clinical environments.
What Is Changing the Technology Landscape?
Innovation is occurring across several layers of glucose monitoring.
The market is experiencing development in:
Microminiaturized devices
Sensor technologies
Transcutaneous monitoring
Continuous glucose monitoring
Bluetooth connectivity
Smartphone integration
Cloud-based monitoring
Digital health platforms
Substitute technologies are also influencing competition. Senseonics' Eversense CGM, for example, uses an implantable sensor to measure interstitial glucose every five minutes and transmit the information to a smartphone.
Regulatory requirements are equally important. European CE-marking expectations around state-of-the-art medicine have raised concerns regarding the positioning of conventional SMBG meters.
Which Regions Will Create the Biggest Opportunities?
North America: North America dominated with 38.0% of revenue in 2025. High diabetes prevalence, advanced healthcare infrastructure, awareness, and favorable reimbursement policies support adoption.
The U.S. held the largest country-level share. CDC data cited in the source indicated that 34.2 million people, or 10.5% of the U.S. population, had diabetes in 2020. Poor diet, obesity, and supportive government measures further influence demand.
Europe: Europe is expected to experience significant growth as awareness and demand for glucose monitoring increase.
The UK benefits from reimbursement policies, patient preference, and key market participants. Germany's market is supported by obesity and diabetes prevalence, while France benefits from established healthcare infrastructure despite unhealthy lifestyle and dietary patterns. Spain is also experiencing increasing demand; approximately 5,141,300 adults had diabetes in 2021.
Asia Pacific: Asia Pacific is expected to record the fastest CAGR from 2026 to 2033.
China held the largest regional share in 2025, supported by its substantial diabetic population. The cited data reported 129 million people with diabetes in China in 2021, representing approximately 8.5% of the population.
Japan's aging population is supporting demand for diabetes monitoring, while India benefits from its large population, rising diabetes prevalence, and improving healthcare infrastructure.
Indonesia is undergoing a transition from conventional finger-stick testing toward digital and continuous monitoring. However, affordability and infrastructure remain important challenges.
Latin America: Latin America offers considerable opportunity because of underdiagnosis and unmet diabetes-management needs. In Brazil, 32% of people living with diabetes remain undiagnosed, while only 25% achieved the recommended HbA1c target before the pandemic.
Middle East & Africa: MEA is expected to expand due to diabetes prevalence, aging populations, and demand for home monitoring.
In South Africa, diabetes affects approximately one in nine adults, while CGMs and newer meters are gradually gaining traction alongside mobile apps and cloud platforms.
Saudi Arabia has a particularly significant opportunity, with diabetes affecting more than one in ten people and approximately 4.27 million people estimated to have diabetes based on the cited IDF data. The UAE is also creating opportunities through healthcare investment and government initiatives. The MiniMed 780G artificial pancreas device was introduced at HealthPlus Diabetes & Endocrinology Center in Abu Dhabi in September 2021.
How Competitive Is the Market?
The market is characterized by substantial innovation and strategic expansion.
Companies such as Medtronic, F. Hoffmann-La Roche, and Abbott have participated in M&A activity to strengthen geographic reach and capabilities. Manufacturers are also expanding regionally to adapt products to local healthcare needs and regulatory requirements.
Key Blood Glucose Monitoring Devices Companies
The key companies identified in the supplied market information include:
Abbott Laboratories
Senseonics Holdings, Inc.
GlucoRx Limited
Zhejiang POCTech Co., Ltd
i-SENS, Inc.
Other important market participants include Medtronic Plc., F. Hoffmann-La Roche Ltd., Dexcom, Inc., Sanofi, Novo Nordisk, Insulet Corporation, Ypsomed Holdings, Glysens Incorporated, Nemaura Medical Inc., Sinocare, Bionime, and AgaMatrix.
These companies compete through product innovation, sensor development, connectivity, regional expansion, partnerships, and M&A activity.
Final Takeaway
The Blood Glucose Monitoring Devices Market is no longer defined only by glucose meters and testing strips. Its next growth phase is being shaped by CGM, connected devices, digital health, home monitoring, sensor innovation, and increasingly personalized diabetes management.
With the market projected to reach USD 30.1 billion by 2033, the combination of rising diabetes prevalence, an aging population, technological innovation, and broader access to monitoring solutions is expected to remain central to market expansion.
About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.
Comments
Log in or sign up to join the conversation.